Matrix γ-carboxyglutamic acid protein is a key regulator of pth-mediated inhibition of mineralization in MC3T3-E1 osteoblast-like cells

Endocrinology

Volumn 142, Issue 10, 2001, Pages 4379-4388

  Gopalakrishnan, R ^a   Ouyang, H ^a   Somerman, M J ^a   McCauley, L K ^a   Franceschi, R T ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; GLUTAMIC ACID DERIVATIVE; MESSENGER RNA; OSTEOPONTIN; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PARATHYROID HORMONE[7-34]; SIALOPROTEIN; UNCLASSIFIED DRUG; WARFARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MINERALIZATION; CALCIUM HOMEOSTASIS; CALVARIA; CARBOXYLATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HORMONE ACTION; HORMONE INHIBITION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0034801887     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.10.8413     Document Type: Article

References (62)

1. Parathyroid hormone and parathyroid hormone-related peptide in calcium homeostasis, bone metabolism and bone development: The proteins, their genes and receptors
2. Parathyroid hormone-related protein-physiological actions
3. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration
4. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation
5. Actions of parathyroid hormone
6. The effects of parathyroid hormone (PTH) and PTH-related peptide on osteoclast resorption of bone slices in vitro: An analysis of pit size and the resorption focus
7. Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts
8. Stimulation of bone matrix apposition in vitro by local growth factors: A comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor β
9. Reversible suppression of in vitro biomineralization by activation of protein kinase A
10. 3′,5′-Cyclic adenosine monophosphate activation in osteoblastic cells: Effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro
11. Parathyroid hormone-related protein downregulates bone sialoprotein gene expression in cementoblasts: Role of the protein kinase A pathway
12. Anabolic actions of parathyroid hormone on bone
13. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
14. Bone sialoprotein
15. Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization
16. Nucleation of hydroxyapatite by bone sialoprotein
17. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins
18. Overexpression of bone sialoprotein using an adenovirus vector restores mineralization in non-mineralizing MC3T3-E1 osteoblast subclones
19. Parathyroid hormone inhibits collagen synthesis and the activity of rat colla1 transgenes mainly by a cAMP-mediated pathway in mouse calvariae
20. Knockout mice lacking bone sialoprotein expression have bone abnormalities
21. Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins
22. The effect of osteocalcin on in vitro lipid-induced hydroxyapatite formation and seeded hydroxyapatite growth
23. Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel
24. The inhibitory effect of cartilage proteoglycans on hydroxyapatite growth
25. The dual role of polyelectrolytes and proteins as mineralization promoters and inhibitors of calcium oxalate monohydrate
26. Effects of fibronectin on hydroxyapatite formation
27. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques
28. 3 in smooth muscle cell migration to osteoponhn in vitro
29. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro
30. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
31. Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin
32. Osteocalcin and ma trix Gla protein: Vitamin K-dependent proteins in bone
33. Gla-containing proteins of bone
34. The matrix Gla protein gene is a marker of the chondrogenesis cell lineage during mouse development
35. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
36. Expression of bone matrix proteins in urolithiasis model rats
37. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome
38. Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb
39. Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization
40. Increased bone formation in osteocalcin-deficient mice
41. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin
42. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential
43. Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts
44. Inorganic phosphate added exogenously or released from β-glycerophosphate initiates mineralization of osteoid nodules in vitro
45. The vitamin K-dependent bone protein is accumulated within cultured osteosarcoma cells in the presence of the vitamin K antagonist warfarin
46. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose
47. Murine bone sialoprotein (BSP): cDNA cloning, mRNA expression, and genetic mapping
48. Mapping of the human and mouse bone sialoprotein and osteopontin loci
49. Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones
50. Ribosomal DNA of fly Sciara coprophila has a very small and homogeneous repeat unit
51. Parathyroid hormone stimutates fra-2 expression in osteoblastic cells in vitro and in vivo
52. Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis
53. Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitro
54. Vitamin K-dependent proteins of bone and cartilage
55. Vitamin K status and bone health: An analysis of methods for determination of undercarboxylated osteocalcin
56. Discordant expression of osteoblast markers in MC3T3-E1 cells that synthesize a high turnover matrix
57. The physiology of parathyroid hormone-related protein: An emerging role as a developmental factor
58. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene
59. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation
60. 3 stimulates the synthesis of matrix γ-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines
61. Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene
62. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide